This Week’s Life Science Headlines

        Litigation Regulatory
Continue reading...

Drug Quality and Security Act

In October of 2012, a meningitis outbreak that caused the death of sixty-four people was traced to tainted steroids purchased from a Compounding Center in New England.  In response to this outbreak, last November President Barack Obama signed the Drug Quality and Security Act into law, which overhauls the FDA’s regulation of Compounding Pharmacies by establishing a system to trace the supply chain of prescription drugs. (See the bill here). Furthermore, under this bill, the FDA is given more authority to regulate and monitor…
Continue reading...

Drug Quality and Security Act

In October of 2012, a meningitis outbreak that caused the death of sixty-four people was traced to tainted steroids purchased from a Compounding Center in New England.  In response to this outbreak, last November President Barack Obama signed the Drug Quality and Security Act into law, which overhauls the FDA’s regulation of Compounding Pharmacies by establishing a system to trace the supply chain of prescription drugs. (See the bill here). Furthermore, under this bill, the FDA is given more authority to regulate and monitor…
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Compounding Pharmacies – Good or Bad?

Compounding pharmacies are no longer serving their original purpose and can potentially be causing more harm than good.  Compounding pharmacies originally converted pills into a liquid form of medicine for individuals who could not swallow pills.  Now, some compounding pharmacies manufacturer prescription drugs in mass quantities and have been tied to outbreaks such as the fungal meningitis outbreak in 2012. There are thirty compounding pharmacies in eighteen states in the United States.  A House subcommittee is holding a hearing on April 16, 2013, to determine…
Continue reading...